Stifel raised the firm’s price target on Cipher Pharmaceuticals (CPHRF) to C$19 from C$17 and keeps a Buy rating on the shares.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener